Cutamesine (SA4503) — Research Compounds Library | RetatrutideCompare
Selective sigma-1 receptor agonist studied for stroke recovery and depression. Phase 2 trials showed safety but mixed efficacy signals.
Selective sigma-1 receptor agonist studied for stroke recovery and depression. Phase 2 trials showed safety but mixed efficacy signals.